ATI RN
ATI RN Custom Exams Set 4
1. Which endocrine disorder would the nurse assess for in the client who has a closed head injury with increased intracranial pressure?
- A. Pheochromocytoma
- B. Diabetes insipidus
- C. Hashimoto's disease
- D. Gynecomastia
Correct answer: B
Rationale: The correct answer is B, Diabetes insipidus. Diabetes insipidus can develop after a head injury due to damage to the hypothalamus or pituitary gland, leading to a deficiency in antidiuretic hormone (ADH). Pheochromocytoma (Choice A) is a tumor of the adrenal gland that causes excessive release of catecholamines, leading to hypertension. Hashimoto's disease (Choice C) is an autoimmune condition affecting the thyroid gland. Gynecomastia (Choice D) refers to the enlargement of breast tissue in males and is not directly related to a closed head injury with increased intracranial pressure.
2. During the admission interview, which question should the nurse ask the male client diagnosed with aorto-iliac disease?
- A. “Do you have trouble sitting for long periods of time?”
- B. “How often do you have a bowel movement and urinate?”
- C. “When you lie down do you feel throbbing in your abdomen?”
- D. “Have you experienced any problems having sexual intercourse?”
Correct answer: D
Rationale: The correct question for the nurse to ask the male client diagnosed with aorto-iliac disease during the admission interview is about any problems experienced during sexual intercourse. Aorto-iliac disease can lead to impaired blood flow to the pelvis and lower extremities, affecting sexual function. Therefore, it is essential to assess the client's sexual health in such cases. The other options, such as sitting for long periods of time, bowel movements and urination frequency, and throbbing sensation when lying down, are not directly related to the potential impact of aorto-iliac disease on sexual function. Hence, they are not the most pertinent questions to ask during the admission interview.
3. Which nursing instruction should the nurse discuss with the client who is receiving glucocorticoids for Addison’s disease?
- A. Discuss the importance of tapering medications when discontinuing medication
- B. Explain that the dose will need to be decreased during times of stress or infection
- C. Instruct the client to take medication on an empty stomach with a glass of water
- D. Encourage the client to wear a MedicAlert bracelet and carry a card in the wallet
Correct answer: A
Rationale: The correct answer is A because tapering glucocorticoids is crucial to prevent adrenal insufficiency, which can occur if the medication is stopped abruptly. Choice B is incorrect as it refers to dose adjustments during stress or infection, not discontinuation. Choice C is incorrect because it does not specifically address the issue of stopping the medication. Choice D is not directly related to the management of glucocorticoid therapy for Addison’s disease.
4. Which question should the healthcare provider ask when assessing the client for an endocrine dysfunction?
- A. “Have you noticed any pain in your legs when walking?”
- B. “Have you had any unexplained weight loss?”
- C. “Have you noticed any change in your bowel movements?”
- D. “Have you experienced any joint pain or discomfort?”
Correct answer: B
Rationale: The correct answer is B: “Have you had any unexplained weight loss?” Unexplained weight loss can be a significant symptom of various endocrine disorders, such as hyperthyroidism and diabetes. Weight changes are often closely linked to endocrine dysfunction due to the hormonal imbalances affecting metabolism. Choices A, C, and D are less specific to endocrine dysfunction. Pain in the legs, changes in bowel movements, and joint pain or discomfort are symptoms that can be related to various health conditions but are not as indicative of endocrine disorders as unexplained weight loss.
5. Warfarin (Coumadin) is an anticoagulant and interferes with the action of:
- A. Platelets
- B. Vitamin K
- C. Calcium
- D. Vitamin B12
Correct answer: B
Rationale: The correct answer is B: Vitamin K. Warfarin works by inhibiting the action of vitamin K, which is crucial for the synthesis of clotting factors in the blood. By interfering with vitamin K, warfarin decreases the production of these clotting factors, thereby prolonging the time it takes for blood to clot. This is why individuals on warfarin therapy need to monitor their vitamin K intake. Choices A, C, and D are incorrect because warfarin does not directly interfere with platelets, calcium, or vitamin B12.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access